VKH
BIOC

Virtu KCG Holdings’s Biocept, Inc. BIOC Stock Holding History

Virtu KCG Holdings’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$24K Buy
+2
New +$28.3K ﹤0.01% 2707
2016
Q2 		– Sell
-1
Closed -$34K – 3434
2016
Q1 		$34K Hold
1
– – ﹤0.01% 2526
2015
Q4 		$52K Hold
1
– – ﹤0.01% 3152
2015
Q3 		$50K Buy
+1
New +$62.5K ﹤0.01% 2999

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu KCG Holdings's BIOC Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Biocept, Inc. (BIOC) in Q2 2017: 2 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #2707 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in BIOC as recently as Q1 2016.

Virtu KCG Holdings first reported a position in BIOC in Q3 2015 and has held it in 4 quarters since. The position peaked at $52K in Q4 2015. 15 funds tracked by Wall St. Rank hold BIOC as of Q2 2017.

  • Virtu KCG Holdings held 2 shares of Biocept, Inc. worth $24K as of Q2 2017.
  • Biocept, Inc. was a new Virtu KCG Holdings position in Q2 2017.
  • Biocept, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2707 holding.
  • Virtu KCG Holdings first reported a position in Biocept, Inc. in Q3 2015 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Biocept, Inc. position peaked at $52K in Q4 2015.
  • 15 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.